C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 323/60 (2006.01) A61K 31/166 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2509042
The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar1, Ar2, Ar3, L1, L2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.
La présente invention a trait à un composé antagoniste à une hormone de concentration en mélanine de formule (I) : Ar?1¿-L?1¿-Ar?2¿-Ar?3¿-L?2¿-Q (I)¿ ?dans laquelle : Ar?1¿, Ar?2¿, Ar?3¿, L¿1?, L?2¿ et Q¿ ?sont tels¿ ?que définis dans la description, ou un sel, solvate, enantiomère ou mélange de diastéréomères pharmaceutiquement acceptables de celui-ci utile dans le traitement, la prévention ou l'amélioration des symptômes liés à l'obésité et des maladies associées.¿?
Gillig James Ronald
Heinz Lawrence Joseph
Kinnick Michael Dean
Lai Yen-Shi
Morin John Michael Junior
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Novel mch receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel mch receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel mch receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1529788